Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iNHL

Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA
ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iNHL ( Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Dec 2021

Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL

Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL ( Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA )
11 Dec 2021

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote
Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )
9 Dec 2021

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
6 Dec 2021

Safety profile of BiTE therapy

Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany
Safety profile of BiTE therapy ( Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany )
2 Dec 2021

Cancer drug policy and access in LMICs

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
26 Nov 2021

Anti-CD38 immunotherapy treatment for multiple myeloma

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Anti-CD38 immunotherapy treatment for multiple myeloma ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )
22 Nov 2021

Paediatric ALL perspective

Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )
12 Nov 2021

Immunotherapy of T-ALL: Opportunities and hurdles

Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA
Immunotherapy of T-ALL: Opportunities and hurdles ( Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA )
10 Nov 2021

Managing immune-related adverse effects in Africa

Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya
Managing immune-related adverse effects in Africa ( Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya )
10 Nov 2021

What to look forward to at AORTIC 2021

Dr Nazik Hammad - Queen's University, Kingston, Canada
What to look forward to at AORTIC 2021 ( Dr Nazik Hammad - Queen's University, Kingston, Canada )
3 Nov 2021

Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma

Prof Wee Joo Chng - National University Cancer Institute, Singapore
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng - National University Cancer Institute, Singapore )
29 Oct 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation